Expertise in Early & Late Phase Trials

Cardiabase's expertise in Phase Trials

Cardiabase has been selected as the preferred provider for Phase I ECG services by 5 of the top 10 pharmaceutical companies and supports a growing number of Phase III multinational trials.

Phase I trials involve large volumes of information to be processed within very tight timeframes and the prompt availability of results can be critical (e.g. for dose escalations).

Phase III trials are usually conducted in various world regions and a large number of sites. The flow of data can vary depending on the pace of patient recruitment and the study progress.

Cardiabase is well prepared to accommodate these fluctuations and process large volumes of data, without any compromise on turnaround times.

The geographical spread of investigative sites in all possible time zones is another logistical challenge (communication, transportation of equipment, customs clearance, technical support, data transfers, etc.) successfully taken up by Cardiabase since 2003.